IXHL (STOCKS)
Incannex Healthcare Limited American Depositary Shares
$3.530000
+0.410000 (+13.14%)
Prev close: $3.120000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Joel Latham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $49.61M
- Employees
- 12
- P/E (TTM)
- -0.15
- P/B (TTM)
- 0.51
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q1)
|
$-0.60 | $-0.94 | +0.3449 | +36.50% |
|
Dec 2025 (Q2)
|
$-0.60 | $-0.94 | +0.3449 | +36.50% |
|
Jun 2025 (Q4)
|
$-15.30 | $-89.29 | +73.9911 | +82.87% |
|
Mar 2025 (Q3)
|
$-238.98 | $-22.16 | -216.8235 | -978.60% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$22.18M |
| Operating Expenses | $26.32M |
| Depreciation and Amortization | $181.00K |
| Research and Development | $9.84M |
| Other Operating Expenses | $16.36M |
| Operating Income/Loss | -$26.32M |
| Income/Loss From Continuing Operations After Tax | -$48.50M |
| Income/Loss From Continuing Operations Before Tax | -$48.50M |
| Net Income/Loss | -$48.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$48.50M |
| Net Income/Loss Available To Common Stockholders, Basic | -$48.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.75 |
| Diluted Earnings Per Share | -$0.75 |
| Basic Average Shares | 695,621,921 |
| Diluted Average Shares | 695,621,921 |
| Assets | $75.01M |
| Current Assets | $74.68M |
| Noncurrent Assets | $328.00K |
| Fixed Assets | $108.00K |
| Other Non-current Assets | $220.00K |
| Liabilities | $1.60M |
| Current Liabilities | $1.55M |
| Wages | $48.00K |
| Other Current Liabilities | $1.50M |
| Noncurrent Liabilities | $53.00K |
| Equity | $73.41M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $73.41M |
| Liabilities And Equity | $75.01M |
| Net Cash Flow From Operating Activities | -$18.43M |
| Net Cash Flow From Operating Activities, Continuing | -$18.43M |
| Net Cash Flow From Investing Activities | -$46.00K |
| Net Cash Flow From Investing Activities, Continuing | -$46.00K |
| Net Cash Flow From Financing Activities | $85.45M |
| Net Cash Flow From Financing Activities, Continuing | $85.45M |
| Exchange Gains/Losses | $117.00K |
| Net Cash Flow | $67.10M |
| Net Cash Flow, Continuing | $66.98M |
| Comprehensive Income/Loss | -$48.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$48.28M |
| Other Comprehensive Income/Loss | -$48.28M |